Omada Health Revenue 2025-2025 | OMDA
Omada Health revenue from 2025 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Omada Health Annual Revenue (Millions of US $) |
|---|
|
Omada Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $68 |
| 2025-06-30 | $61 |
| 2024-12-31 | |
| 2024-09-30 | $46 |
| 2024-06-30 | $41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.933B | $0.000B |
| Omada Health Inc. provides a range of virtual care programs principally in the United States. The company offers cardiometabolic programs for prediabetes, diabetes and hypertension; a physical therapy program to address musculoskeletal conditions other support programs. Omada Health Inc. is based in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.818B | 31.00 |
| HCA Healthcare (HCA) | United States | $108.237B | 17.92 |
| CVS Health (CVS) | United States | $102.012B | 11.73 |
| Elevance Health (ELV) | United States | $83.333B | 12.22 |
| Cencora (COR) | United States | $66.377B | 21.40 |
| Natera (NTRA) | United States | $32.568B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $20.757B | 15.83 |
| Medpace Holdings (MEDP) | United States | $16.879B | 41.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.455B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Solventum (SOLV) | United States | $14.863B | 14.43 |
| Viatris (VTRS) | United States | $14.604B | 5.44 |
| ICON (ICLR) | Ireland | $14.548B | 14.44 |
| Revvity (RVTY) | United States | $11.779B | 21.69 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.769B | 20.74 |
| Avantor (AVTR) | United States | $8.373B | 12.79 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| HealthEquity (HQY) | United States | $7.224B | 27.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.223B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.036B | 41.95 |
| PACS (PACS) | United States | $6.501B | 39.53 |
| Bausch + Lomb (BLCO) | Canada | $6.199B | 40.70 |
| Sotera Health (SHC) | United States | $5.395B | 26.01 |
| Alignment Healthcare (ALHC) | United States | $4.258B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.447B | 60.53 |
| Concentras Parent (CON) | United States | $2.642B | 16.49 |
| Progyny (PGNY) | United States | $2.450B | 48.17 |
| Organon (OGN) | United States | $2.111B | 2.22 |
| Surgery Partners (SGRY) | United States | $2.106B | 27.13 |
| Pediatrix Medical (MD) | United States | $1.946B | 11.62 |
| Establishment Labs Holdings (ESTA) | United States | $1.940B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.287B | 0.00 |
| Nutex Health (NUTX) | United States | $1.278B | 9.77 |
| Ardent Health (ARDT) | United States | $1.269B | 4.14 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.978B | 16.00 |
| Embecta (EMBC) | United States | $0.761B | 4.33 |
| InnovAge Holding (INNV) | United States | $0.754B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| CryoPort (CYRX) | United States | $0.533B | 0.00 |
| Enhabit (EHAB) | United States | $0.516B | 23.16 |
| Strata Critical Medical (SRTA) | United States | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Agilon Health (AGL) | United States | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.379B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.70 |
| Shoulder Innovations (SI) | United States | $0.292B | 0.00 |
| So-Young (SY) | China | $0.278B | 0.00 |
| KindlyMD (NAKA) | United States | $0.203B | 0.00 |
| LifeMD (LFMD) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.144B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |